Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3912]
News [11313]
Articles [47]
Editorials [10]
Conferences [196]
elearning [4]
Idelalisib shows promising results in patients with double refractory indolent...
Dr Andrew Davies - Southampton General Hospital, Southampton, UK;
Idelalisib shows promising results in patients with double refractory indolent B-cell non-Hodgkin's lymphoma ( Dr Andrew Davies - Southampton General Hospital, Southampton, UK; )
9 May 2014
Rituximab versus idelalisib in refractory CLL
Prof John Gribben - Queen Mary University London, London, UK; Prof Peter...
Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )
9 May 2014
New agents extend progression-free survival in double refractory myeloma
Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta...
New agents extend progression-free survival in double refractory myeloma ( Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta, USA )
8 May 2014
Aspirin analogues developed for anti-cancer effects on leukaemia
Dr Chris Pepper - Cardiff University School of Medicine, Cardiff, UK
Aspirin analogues developed for anti-cancer effects on leukaemia ( Dr Chris Pepper - Cardiff University School of Medicine, Cardiff, UK )
8 May 2014
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic...
Dr Valentin Goede - University of Cologne, Cologne, Germany
Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients ( Dr Valentin Goede - University of Cologne, Cologne, Germany )
8 May 2014
WIN Symposium 2014: Breakthrough biomarker investigations and combination...
Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg
WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies ( Dr John Mendelsohn, Dr Razelle Kurzrock, Dr Mace Rothenberg )
6 May 2014
Surgical strategies available for renal cell carcinoma with inferior vena cava...
Prof Christopher G. Wood - The University of Texas MD Anderson Cancer Center...
Surgical strategies available for renal cell carcinoma with inferior vena cava invasion ( Prof Christopher G. Wood - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 May 2014
Use of robotics in kidney cancer surgery
Dr Christophe Vaessen - Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Use of robotics in kidney cancer surgery ( Dr Christophe Vaessen - Groupe Hospitalier Pitié-Salpêtrière, Paris, France )
6 May 2014
Work and history of the Kidney Cancer Association
Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer...
Work and history of the Kidney Cancer Association ( Carrie Konosky - Vice President of Development & Public Affairs, Kidney Cancer Association, Chicago, USA )
6 May 2014
Intratumour heterogeneity in renal and lung cancer
Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK
Intratumour heterogeneity in renal and lung cancer ( Prof Charles Swanton - CRUK London Research Institute and UCL, London, UK )
6 May 2014
Kidney cancer treatment ten years from now
Prof Martin Gore - The Royal Marsden Hospital, London, UK
Kidney cancer treatment ten years from now ( Prof Martin Gore - The Royal Marsden Hospital, London, UK )
6 May 2014
High levels of mutated p53 indicate metastatic phenotype
Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center...
High levels of mutated p53 indicate metastatic phenotype ( Dr Guillermina Lozano - The University of Texas MD Anderson Cancer Center, Houston, USA )
5 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation